define({"0":{y:0,u:"../Content/MainTopics/What_is_covid19.htm",l:-1,t:"What is COVID-19 ",i:0.0437636761487964,a:" COVID-19 is an acute respiratory infectious disease caused by infection with SARS-CoV-2 virus (commonly known as coronavirus). It was first recognized and described in November 2019, in central China (Wuhan city, Hubei province) during a series of cases that initiated a pandemic of the disease. ..."},"1":{y:0,u:"../Content/MainTopics/Statistics.htm",l:-1,t:"Statistics",i:0.0437636761487964,a:"At the moment (on 16 April, 2021), the following statistics are recorded in Poland: Total number of infected: 2,660,088 (+17,847 in 24 hours) Number of dead: 61 208 (+595) Number of people who recovered: 2 255 232 (+17 373) Number of active cases of infection: 343 648 (+656) Number of people ..."},"2":{y:0,u:"../Content/MainTopics/Symptoms_of_covid19.htm",l:-1,t:"Symptoms of COVID-19",i:0.0437636761487964,a:"Each case of COVID-19 has an individual course. Most infected individuals develop symptoms of mild to moderate severity. Such individuals recover without the need for hospitalisation. The most common symptoms are: fever dry cough fatigue Less common symptoms are: muscle pain sore throat diarrhoea ..."},"3":{y:0,u:"../Content/MainTopics/Additional_information.htm",l:-1,t:"Additional information",i:0.0437636761487964,a:"If you experience serious symptoms, contact your doctor immediately. Call and make an appointment before visiting your doctor or medical facility. People with mild symptoms and no other medical conditions should manage their symptoms at home. However, remember that the incubation period of the virus ..."},"4":{y:0,u:"../Content/MainTopics/How_not_to_get_ill.htm",l:-1,t:"How not to get ill - safety rules",i:0.0437636761487964,a:"How not to get ill - safety rules Protect yourself and people around you. Know the facts and take appropriate precautions. Follow the recommendations of your local health and epidemiological station. Â "},"5":{y:0,u:"../Content/MainTopics/To_prevent_the_spread_of_covid 19.htm",l:-1,t:"To prevent the spread of COVID-19",i:0.0437636761487964,a:"Wash your hands frequently - at least several times a day and every time you come home from outdoors. Use soapy water and an alcohol-based disinfectant. Keep a safe distance (1,5 - 2 metres) from people coughing and sneezing. Wear a mask when distance is not possible. Do not touch your eyes, nose or ..."},"6":{y:0,u:"../Content/MainTopics/Masks.htm",l:-1,t:"Masks",i:0.0809628008752731,a:"Masks can help prevent the transmission of viruses from the person wearing the mask to others. Masks alone do not protect against COVID-19 - you should also keep your distance from other people and take care with hand hygiene. Follow the recommendations of your local health and epidemiological ..."},"7":{y:0,u:"../Content/MainTopics/Contact_with_a_sick_or_infected_person.htm",l:-1,t:"Contact with a sick or infected person",i:0.0437636761487964,a:"Contact with a sick or infected person If you suspect you have been in contact with someone infected with coronavirus, determine the type of contact and monitor your wellbeing. What else should you do? Determine whether the contact was close or not."},"8":{y:0,u:"../Content/MainTopics/What_if_the_contact_was_not_close.htm",l:-1,t:"What if the contact was not close?",i:0.0437636761487964,a:"First of all, remember the situation in which you came into contact with a sick person. If the contact was brief, from a distance of more than 2 metres, the risk of infection is low. In this case, keep an eye on your health, take care of yourself and behave in a safe manner. You do not have to go ..."},"9":{y:0,u:"../Content/MainTopics/What_if_the_contact_was_close.htm",l:-1,t:"What if the contact was close?",i:0.0437636761487964,a:"First of all - don\u0027t panic.  If the contact with the infected person was closer than 2 metres and longer than 15 minutes (being in the same room, direct conversation), if there was physical contact (e.g. shaking hands, touching a used tissue, exposure to coughing), ...there is a greater likelihood ..."},"10":{y:0,u:"../Content/MainTopics/After_contact_with_an_infected_person.htm",l:-1,t:"What to do after contact with a person infected with COVID-19?",i:0.0437636761487964,a:"Inform  The Social Insurance Institution  by telephone about the  quarantine , and they do the rest. You do not need an electronic sick note or a certificate from the health authorities. However, it is worth notifying your boss by e-mail or telephone of the reason for your absence from work. If, ..."},"11":{y:0,u:"../Content/MainTopics/If_I_am_referred_for_a_test.htm",l:-1,t:"If I get request for a COVID-19 test",i:0.0437636761487964,a:"If I get request for a COVID-19 test Referring for a test by your GP changes your situation. A negative result automatically ends the quarantine. A positive result means infection and isolation. In this situation your housemates have to be quarantined. "},"12":{y:0,u:"../Content/MainTopics/If_you_become_ill.htm",l:-1,t:"If you become ill",i:0.0437636761487964,a:"Inform  the sanitary-epidemiological station . Get tested: You can sign up for the test online. Just fill in the form available here. Answer a few questions. Based on the data you have provided, the system determines whether you are eligible for the test. If you have symptoms indicating SARS-CoV-2 ..."},"13":{y:0,u:"../Content/MainTopics/Sharing_a_household.htm",l:-1,t:"What if someone you share a household with falls ill?",i:0.0437636761487964,a:"Ideally, a COVID-19 patient should have their own separate room with a bathroom and toilet Masks  should be worn by all family members including the patient Frequent washing or disinfection of hands and disinfection of objects and shared surfaces is very important The home should be ventilated as ..."},"14":{y:0,u:"../Content/MainTopics/After_the_illness.htm",l:-1,t:"What can happen after the illness?",i:0.0437636761487964,a:"Most patients recover from COVID-19 and return to normal activities, but for some, especially those with a severe infection, symptoms may persist for weeks or even months. Older people and those with co-morbidities are most at risk of persistent COVID-19 symptoms. Occasionally, even young people who ..."},"15":{y:0,u:"../Content/MainTopics/Covid-19_vaccine.htm",l:-1,t:"COVID-19 vaccine - characteristics and types",i:0.0437636761487964,a:"Developing a new vaccine is a long and complex process. Each vaccine formulation must successfully pass through successive stages of laboratory testing, preclinical animal studies and human clinical trials. Research on the COVID-19 vaccine began as soon as the genetic sequence of the SARS-CoV-2 ..."},"16":{y:0,u:"../Content/MainTopics/Adverse_reactions.htm",l:-1,t:"Adverse reactions",i:0.0437636761487964,a:"Following administration of the vaccines (mRNA, vector and subunit), adverse reactions may occur in the form of injection site pain, fatigue, headache, muscle pain and chills, joint pain, fever and swelling at the injection site. See below for information on adverse reactions to the vaccine."},"17":{y:0,u:"../Content/MainTopics/Vaxzevria_Astra-Zeneca_vaccine.htm",l:-1,t:"Astra-Zeneca vaccine (Vaxzevria)",i:0.0437636761487964,a:"The most commonly reported adverse reactions were: tenderness at the injection site (63.7%), pain at the injection site (54.2%), headache (52.6%), fatigue (53.1%), muscle pain (44.0%), malaise (44.2%), fever (including feeling feverish (33.6%) and fever \u003e38oC (7.9%)) chills (31.9%), joint pain ..."},"18":{y:0,u:"../Content/MainTopics/Moderna_vaccine.htm",l:-1,t:"Moderna vaccine",i:0.0437636761487964,a:"The most commonly reported adverse reactions were: pain at the injection site (92%), fatigue (70%), headache (64.7%), muscle pain (61.5%), joint pain (46.4%), chills (45.4%), nausea/vomiting (23%), swelling/ tenderness in the armpit (19.8%), fever (15.5%), swelling at injection site (14.7%), redness ..."},"19":{y:0,u:"../Content/MainTopics/COMIRNATY_vaccine_Pfizer.htm",l:-1,t:"COMIRNATY vaccine (from BioNTech and Pfizer)",i:0.0437636761487964,a:"The most common adverse reactions in participants aged 16 years or older were: injection site pain (\u003e80%), fatigue (\u003e60%), headache (\u003e50%), muscle pain and chills (\u003e30%), joint pain (\u003e20%), fever and swelling at the injection site (\u003e10%). These events were usually mild to moderate in severity and ..."},"20":{y:0,u:"../Content/MainTopics/Johnson_and_Johnson_vaccine.htm",l:-1,t:"Johnson \u0026 Johnson vaccine",i:0.0437636761487964,a:"Johnson \u0026 Johnson vaccine The most common systemic adverse reactions were: headache (38.9%) fatigue (38.2%) muscle pain (33.2%) nausea (14.2%). Most adverse reactions occurred within 1-2 days after vaccination and were mild to moderate in intensity and of short duration (1-2 days)."},"21":{y:0,u:"../Content/MainTopics/Glosariusz.htm",l:-1,t:"Glossary",i:0.0437636761487964,a:"Glossary"},});